Literature DB >> 33414433

LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells.

Minmin Xiong1, Mengshi Wu1, Weijun Huang1, Zehong Chen2, Haoxian Ke1, Zewen Chen3, Wu Song2, Yonghua Zhao4, Andy P Xiang1, Xiaomin Zhong5.   

Abstract

Long non-coding RNA (lncRNA) DANCR has been reported to participate in key processes such as stem cell differentiation and tumorigenesis. In a high throughput screening for lncRNAs involved in Doxorubicin-induced apoptosis, we found DANCR was suppressed by Doxorubicin and it acted as an important repressor of apoptosis in colorectal cancer. Further studies demonstrated that DANCR promoted the oncogenic lncRNA MALAT1 expression via enhancing the RNA stability of MALAT1 to suppress apoptosis. MALAT1 could efficiently mediate the suppressive function of DANCR on apoptosis. Mechanistic studies found the RNA-binding protein QK served as an interacting partner of both DANCR and MALAT1, and the protein level of QK was subjected to the regulation by DANCR. Furthermore, QK was able to modulate the RNA stability of MALAT1, and the interaction between QK and MALAT1 was controlled by DANCR. In addition, QK could mediate the function of DANCR in regulating the expression of MALAT1 and suppressing apoptosis. These results revealed DANCR played a critical role in Doxorubicin-induced apoptosis in colorectal cancer cells, which was achieved by the interaction between DANCR and QK to enhance the expression of MALAT1.

Entities:  

Year:  2021        PMID: 33414433      PMCID: PMC7791116          DOI: 10.1038/s41419-020-03318-8

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  59 in total

1.  Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells.

Authors:  Feng Yang; Jianwei Bi; Xuchao Xue; Luming Zheng; Kangkang Zhi; Jide Hua; Guoen Fang
Journal:  FEBS J       Date:  2012-07-31       Impact factor: 5.542

2.  Methyltransferase-like protein 16 binds the 3'-terminal triple helix of MALAT1 long noncoding RNA.

Authors:  Jessica A Brown; Charles G Kinzig; Suzanne J DeGregorio; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

3.  Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein.

Authors:  Lixia Zhao; Mariana D Mandler; Hong Yi; Yue Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

Review 4.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

5.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Authors:  Hiroshi Hirata; Yuji Hinoda; Varahram Shahryari; Guoren Deng; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer Res       Date:  2015-01-19       Impact factor: 12.701

6.  Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.

Authors:  Pei Yen Yeh; Shuang-En Chuang; Kun-Huei Yeh; Ying Chyi Song; Lucia Ling-Yuan Chang; Ann-Lii Cheng
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

7.  Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.

Authors:  April C Childs; Sharon L Phaneuf; Amie J Dirks; Tracey Phillips; Christiaan Leeuwenburgh
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

8.  Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.

Authors:  Lu Jin; Huifang Fu; Jing Quan; Xiang Pan; Tao He; Jia Hu; Yifan Li; Hang Li; Yu Yang; Jing Ye; Fangting Zhang; Liangchao Ni; Shangqi Yang; Yongqing Lai
Journal:  Mol Med Rep       Date:  2017-08-02       Impact factor: 2.952

Review 9.  Doxorubicin and multidrug resistance.

Authors:  G D Kruh; L J Goldstein
Journal:  Curr Opin Oncol       Date:  1993-11       Impact factor: 3.645

10.  XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure.

Authors:  C M Clemson; J A McNeil; H F Willard; J B Lawrence
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more
  9 in total

1.  Regulating Oncogenic LncRNA DANCR with Targeted ECO/siRNA Nanoparticles for Non-Small Cell Lung Cancer Therapy.

Authors:  Calin Nicolescu; Amita Vaidya; Andrew Schilb; Zheng-Rong Lu
Journal:  ACS Omega       Date:  2022-06-17

Review 2.  A review on the role of DANCR in the carcinogenesis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Aria Baniahmad; Mohammad Taheri; Mohammad Samadian
Journal:  Cancer Cell Int       Date:  2022-05-19       Impact factor: 6.429

Review 3.  GBDTLRL2D Predicts LncRNA-Disease Associations Using MetaGraph2Vec and K-Means Based on Heterogeneous Network.

Authors:  Tao Duan; Zhufang Kuang; Jiaqi Wang; Zhihao Ma
Journal:  Front Cell Dev Biol       Date:  2021-12-17

Review 4.  The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers.

Authors:  Faiza Naz; Imran Tariq; Sajid Ali; Ahmed Somaida; Eduard Preis; Udo Bakowsky
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

Review 5.  Regulation of Pyroptosis by ncRNA: A Novel Research Direction.

Authors:  Liyuan Gao; Zhitao Jiang; Yi Han; Yang Li; Xiang Yang
Journal:  Front Cell Dev Biol       Date:  2022-03-28

6.  The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway.

Authors:  Ruolan Zhang; Yuming Hao; Jinrong Zhang
Journal:  Cell Mol Biol Lett       Date:  2022-02-17       Impact factor: 5.787

Review 7.  MALAT1-related signaling pathways in colorectal cancer.

Authors:  Wen-Wen Xu; Jin Jin; Xiao-Yu Wu; Qing-Ling Ren; Maryam Farzaneh
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

8.  Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions.

Authors:  Anna Siskova; Jan Kral; Jana Drabova; Klara Cervena; Kristyna Tomasova; Jiri Jungwirth; Tomas Hucl; Pavel Kohout; Sandra Summerova; Ludmila Vodickova; Pavel Vodicka; Veronika Vymetalkova
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

9.  Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.

Authors:  Likun Luan; Youguo Dai; Tao Shen; Changlong Yang; Zhenpu Chen; Shan Liu; Junyi Jia; Zhenhui Li; Shaojun Fang; Hengqiong Qiu; Xianshuo Cheng; Zhibin Yang
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.